• 1
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277300
  • 2
    Kang JS, Maygarden SJ, Mohler JL, Pruthi RS. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer. BJU Int 2004; 93: 120710
  • 3
    Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer 2006; 107: 7582
  • 4
    Hamilton RJ, Aronson WJ, Presti JC Jr et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer 2007; 110: 22029
  • 5
    Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am 1996; 2: 22533
  • 6
    Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. Cancer Res 1995; 55: 39735
  • 7
    Glover FE Jr, Coffey DS, Douglas LL et al. The epidemiology of prostate cancer in Jamaica. J Urol 1998; 159: 19846; discussion 1986–7
  • 8
    Blake G, Hanchard B, Mitchell K et al. Jamaica cancer mortality statistics, 1999. West Indian Med J 2002; 51: 647
  • 9
    Coard KC, Skeete DH. A 6-year analysis of the clinicopathological profile of patients with prostate cancer at the University Hospital of the West Indies, Jamaica. BJU Int 2009; 103: 14826
  • 10
    Ritch CR, Brendler CB, Wan RL, Pickett KE, Sokoloff MH. Relationship of erythrocyte membrane polyunsaturated fatty acids and prostate-specific antigen levels in Jamaican men. BJU Int 2004; 93: 12115
  • 11
    Ritch CR, Wan RL, Stephens LB et al. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol 2007; 177: 97101
  • 12
    Jackson MD, Walker SP, Simpson-Smith CM et al. Associations of whole-blood fatty acids and dietary intakes with prostate cancer in Jamaica. Cancer Causes Control 2012; 23: 2333
  • 13
    Cross CK, Shultz D, Malkowicz SB et al. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol 2002; 20: 28638
  • 14
    Morrison BF, Coard K, Strachan G, Miller R, Aiken W, Mayhew R. Radical prostatectomy outcomes at the University Hospital of the West Indies: 2000–2007. West Indian Med J 2011; 60: 6872
  • 15
    Moul JW, Douglas TH, McCarthy WF, McLeod DG. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 1996; 155: 166773
  • 16
    Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology 2000; 56: 8791
  • 17
    Laudano MA, Badani KK, McCann TR et al. Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black than in white men. Urology 2009; 74: 6604
  • 18
    Powell IJ, Dey J, Dudley A et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology 2002; 59: 90712
  • 19
    von Bodman C, Matikainen MP, Yunis LH et al. Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy. Urology 2010; 76: 10926
  • 20
    Nielsen ME, Han M, Mangold L et al. Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center. J Urol 2006; 176: 5159
  • 21
    Chu DI, Moreira DM, Gerber L et al. Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer 2012 [Epub ahead of print]. DOI:10.1002/cncr.27456
  • 22
    Gaston KE, Kim D, Singh S, Ford OH 3rd, Mohler JL. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 2003; 170: 9903
  • 23
    Kim HS, Moreira DM, Jayachandran J et al. Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men. Prostate Cancer Prostatic Dis 2011; 14: 2625